GetItWebbed
0%
Blog/Research
Research

Brain-Computer Interfaces: Where Neuroscience Meets Silicon

Manas Garge
Manas Garge·May 14, 2026·8 min read
Brain-Computer Interfaces: Where Neuroscience Meets Silicon

Brain-computer interfaces have occupied the frontier of science fiction for decades. In 2025, they're graduating from research labs to early clinical trials — still far from consumer products, but close enough to real patients with real conditions that the engineering and ethical questions are now urgent rather than theoretical.

The Two Camps: Invasive vs. Non-Invasive

BCIs split into two fundamentally different approaches. Invasive BCIs require surgical implantation of electrodes directly into or on the brain tissue, offering high signal quality and bandwidth but carrying surgical risk. Non-invasive BCIs use external sensors — EEG caps, fNIRS headbands, or dry electrodes — that are safe and wearable but capture noisier, lower-resolution signals. The right choice depends entirely on the application: for restoring motor function in a paralyzed patient, invasive systems are worth the risk. For gaming or meditation apps, non-invasive is the only acceptable path.

State of Research in 2025

  • Neuralink N1: wireless implant enabling a quadriplegic patient to control a computer cursor with 8x8 electrode array
  • BrainGate consortium: academic program demonstrating speech synthesis from motor cortex signals in ALS patients
  • Meta's non-invasive typing BCI: wrist-based EMG device achieving 90 words per minute from forearm nerve signals
  • Synchron Stentrode: stent-delivered electrode array placed via blood vessels — no open-brain surgery required

Ethical Questions We Can't Ignore

BCIs raise questions that existing bioethics frameworks aren't fully equipped to handle. Who owns the neural data generated by an implant? What happens if the company manufacturing your brain implant goes bankrupt? Can an employer legally require proof of cognitive performance? Can a BCI be used to detect intent before action? These aren't hypothetical future questions — the Neuralink trials have made them present-tense policy problems that regulators are actively working through.

The question with BCIs has never been whether they'll work. It's always been whether we've thought through what happens when they do.

Manas Garge

Written by Manas Garge

Founder & Data Engineer

All Articles
    GetItWebbed